RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 6,000 research publications. Research title with ★ indicates InBody recommended paper.

Printable list of studies

Download Annual Studies PDF

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

Endocrinology
Author
S Yagi et al.
Used Parameters : SMM
Publication Year : 2017
Country : Japan
Journal : Diabetology & Metabolic Syndrome
It is unknown whether canagliflozin, a selective sodium glucose co-transporter 2 inhibitor, reduces epicardial adipose tissue (EAT) thickness, which is associated with insulin resistance and is a risk factor for coronary artery disease. We administered 100 mg of canagliflozin for 6 months to 13 patients with type 2 diabetes mellitus. We evaluated glycemic control, visceral adipose tissue (VAT) area and subcutaneous adipose tissue (SAT) area, and skeletal muscle mass by using impedance methods, and EAT thickness by using …
Full text
List
Powered by KBoard